Karin Walker
Director/Board Member at CYCLACEL PHARMACEUTICALS, INC.
Net worth: 11 106 $ as of 2024-05-30
Profile
Karin L.
Walker is an Independent Non-Executive Director at Cyclacel Pharmaceuticals, Inc. since 2020.
She is also the Chief Accounting Officer at Prothena Corp.
Plc since 2013.
Previously, she served as an Independent Director at LifeSci Acquisition Corp.
in 2020 and as the Chief Accounting Officer & Vice President-Finance at Affymax, Inc. from 2012 to 2013.
Ms. Walker also worked as an Accountant at Ernst & Young US LLP and as the Vice President-Finance & Controller at CV Therapeutics, Inc. from 2006 to 2009.
She held the same position at Amyris, Inc. from 2009 to 2012.
Ms. Walker obtained her undergraduate degree from California Polytechnic State University (San Luis Obispo).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-05-02 | 4,207 ( 0.29% ) | 11 106 $ | 2024-05-30 |
Karin Walker active positions
| Companies | Position | Start |
|---|---|---|
| PROTHENA CORPORATION PLC | Comptroller/Controller/Auditor | 2013-05-19 |
| CYCLACEL PHARMACEUTICALS, INC. | Director/Board Member | 2020-11-08 |
Former positions of Karin Walker
| Companies | Position | End |
|---|---|---|
| VINCERX PHARMA, INC. | Director/Board Member | 2020-12-22 |
| AFFYMAX, INC. | Comptroller/Controller/Auditor | 2013-04-30 |
| AMYRIS, INC. | Comptroller/Controller/Auditor | 2012-08-31 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Comptroller/Controller/Auditor | 2009-07-31 |
Ernst & Young US LLP
 Ernst & Young US LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young US LLP was engaged in providing accounting services. The company was headquartered in Pittsburgh, PA. | Corporate Officer/Principal | - |
Training of Karin Walker
| California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| AFFYMAX, INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| AMYRIS, INC. | Process Industries |
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
LifeSci Acquisition Corp.
 LifeSci Acquisition Corp. Financial ConglomeratesFinance LifeSci Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded on December 19, 2018 and is headquartered in New York, NY. | Finance |
Ernst & Young US LLP
Ernst & Young US LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young US LLP was engaged in providing accounting services. The company was headquartered in Pittsburgh, PA. | Commercial Services |
- Stock Market
- Insiders
- Karin Walker
